Publicaciones (38) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. Antiproliferative effect of boldine on neural progenitor cells and on glioblastoma cells

    Frontiers in Neuroscience, Vol. 17

  2. Impact of reflex locomotion and the Bobath concept on clinical and biomolecular parameters in people with multiple sclerosis: study protocol for a randomized controlled trial

    Frontiers in Neurology, Vol. 14

  3. Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

    Journal of Visualized Experiments, Vol. 2023, Núm. 196

2022

  1. Src: coordinating metabolism in cancer

    Oncogene, Vol. 41, Núm. 45, pp. 4917-4928

2021

  1. Efecto de la región de conexina43 inhibidora de Src en células madre de cáncer de pulmón

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 51

  2. Efecto del péptido antitumoral TAT-Cx43266-283 en células madre neurales en un modelo de glioma in vivo

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 84

  3. Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))

    EBioMedicine

  4. Erratum: Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo (Neuro-Oncology DOI: 10.1093/neuonc/noz243)

    Neuro-Oncology

  5. Impairment of autophagic flux participates in the antitumor effects of tat-cx43266-283 in glioblastoma stem cells

    Cancers, Vol. 13, Núm. 17

  6. Purinergic receptor blockade with suramin increases survival of postnatal neural progenitor cells in vitro

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-14

  7. Péptidos penetrantes para atacar al glioma y su microambiente

    VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 50

  8. Recent advances on immunosuppressive drugs and remyelination enhancers for the treatment of multiple sclerosis

    Current Pharmaceutical Design, Vol. 27, Núm. 30, pp. 3273-3280

  9. geno5mC: A Database to Explore the Association between Genetic Variation (SNPs) and CpG Methylation in the Human Genome

    Journal of Molecular Biology, Vol. 433, Núm. 11

2020

  1. Christian Giaume (November 1951-July 2019)

    Glia, Vol. 68, Núm. 7, pp. 1321-1328

  2. Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

    Neuro-Oncology, Vol. 22, Núm. 4, pp. 493-504

  3. Connexin43 region 266–283, via src inhibition, reduces neural progenitor cell proliferation promoted by egf and fgf-2 and increases astrocytic differentiation

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-22

  4. Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome Mice

    The Journal of nutrition, Vol. 150, Núm. 6, pp. 1631-1643

  5. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283

    EBioMedicine, Vol. 62

  6. mirnaQC: A webserver for comparative quality control of miRNA-seq data

    Nucleic Acids Research, Vol. 48, Núm. W1, pp. W262-W267

2019

  1. Connexins in cancer: bridging the gap to the clinic

    Oncogene, Vol. 38, Núm. 23, pp. 4429-4451